Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
India · Delayed Price · Currency is INR 1,704.60
+9.50 (0.56%)
At close: Feb 9, 2026
Sun Pharmaceutical Industries Employees
Sun Pharmaceutical Industries had 43,000 employees as of March 31, 2025. The number of employees did not change compared to the previous year.
Employees
43,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
13.21M INR
Profits / Employee
2.54M INR
Market Cap
4.07T
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 43,000 | 0 | - |
| Mar 31, 2024 | 43,000 | 2,000 | 4.88% |
| Mar 31, 2023 | 41,000 | 3,000 | 7.89% |
| Mar 31, 2022 | 38,000 | 1,000 | 2.70% |
| Mar 31, 2021 | 37,000 | 1,000 | 2.78% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cipla | 30,313 |
| Zydus Lifesciences | 27,917 |
| Aurobindo Pharma | 27,707 |
| Mankind Pharma | 26,978 |
| Alkem Laboratories | 18,785 |
| Ipca Laboratories | 16,778 |
| Glenmark Pharmaceuticals | 15,800 |
| Divi's Laboratories | 10,542 |
Sun Pharmaceutical Industries News
- 6 days ago - India-US trade deal clarity: Pharma exporters gain edge in US; sector eyes growth boost - The Times of India
- 6 days ago - Sun Pharma receives FDA Rare Pediatric Disease Priority Review Voucher for Sezaby - Business Upturn
- 6 days ago - Sun Pharmaceuticals Industries Ltd (BOM:524715) Q3 2026 Earnings Call Highlights: Strong Sales ... - GuruFocus
- 6 days ago - Q3 2026 Sun Pharmaceutical Industries Ltd Earnings Call Transcript - GuruFocus
- 8 days ago - Pharma sector stocks today, Feb 1: Shilpa Medicare rally 8%, Sun Pharma up 3%, Aurobindo Pharma falls 2.21% - Business Upturn
- 8 days ago - Sun Pharma shares jump over 3% as revenue rises 13.5% YoY to Rs 15,469.1 crore, net profit up 16% - Business Upturn
- 9 days ago - Sun Pharma board declares interim dividend of Rs 11 per share for FY26 - Business Upturn
- 9 days ago - Sun Pharma Q3 Results: Revenue jumps 15.1% YoY to Rs 15,469.1 crore, net profit up 16% - Business Upturn